Windlas Biotech Limited (NSE:WINDLAS)
816.00
+8.35 (1.03%)
Jun 19, 2026, 3:30 PM IST
-9.16% (1Y)
| Market Cap | 16.84B -11.7% |
| Revenue (ttm) | 9.04B +19.0% |
| Net Income | 664.56M +9.0% |
| EPS | 31.15 +7.9% |
| Shares Out | 20.64M |
| PE Ratio | 26.20 |
| Forward PE | n/a |
| Dividend | 6.30 (0.77%) |
| Ex-Dividend Date | Jul 21, 2025 |
| Volume | 44,783 |
| Open | 807.65 |
| Previous Close | 807.65 |
| Day's Range | 803.05 - 830.00 |
| 52-Week Range | 697.40 - 1,097.90 |
| Beta | 0.27 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 5, 2026 |